A detailed history of Golden State Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 146 shares of MRNA stock, worth $4,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146
Holding current value
$4,907
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$36.85 - $63.93 $5,380 - $9,333
146 New
146 $6.07 Million
Q2 2020

Aug 11, 2020

SELL
$29.67 - $80.0 $89,010 - $240,000
-3,000 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$17.78 - $31.58 $53,340 - $94,740
3,000 New
3,000 $90,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $13.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Golden State Wealth Management, LLC Portfolio

Follow Golden State Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Wealth Management, LLC with notifications on news.